About Us

---

SyNoesis Therapeutics is developing precision therapeutics and digital biomarkers for chronic diseases.

We operate at the intersection of:

- Nuclear receptor pharmacology

- Translational biomarkers

- Clinical AI

- Regulatory-grade development

Mission: To deliver disease-modifying precision therapeutics and predictive biomarker platforms that intervene before irreversible deterioration occurs.

Vision:To become a European leader in precision neurotherapeutics and translational risk-intelligence systems.

SyNoesis is led by a hands-on scientific team balanced with pharma executives with  long industry expertise.